BSE

Shasun Pharmaceuticals Ltd.[Merged]

524552 SHASUNPHAR Group (B)

17 Nov,15:41

428.85
22.50 (5.54%)

HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist

Refresh

Zoom

Day

6Mn

Volume	Prev close	Day's H/L (Rs.)	52wk H/L (Rs.)	Mkt Cap (Rs. Cr)	Shasun Pharmaceuticals Ltd.[Merged] BUY SELL
79,828	406.35	432.05 - 407.80	432.05 - 209.80	2,884.25	Shasun Pharmaceuticals Ltd.[Merged] BUY SELL

(Rs. Crore)

Financial Results of Shasun Pharmaceuticals Ltd.[Merged]

	Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12	Mar ' 11
Sales	1,078.40	934.72	782.76	735.91	567.85
Operating profit	112.90	89.45	68.13	51.52	39.16
Interest	45.61	35.62	26.49	30.48	21.50
Gross profit	81.21	66.10	55.30	62.00	32.11
EPS (Rs)	6.87	6.22	4.64	9.63	1.01

See more in Research Center »

Statements:Balance Sheet | P&L | Cash Flow

More:Dividend | Bonus | Share Holding | Capital Structures | Ratios

About Shasun Pharmaceuticals Ltd.[Merged]

Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia

News for Pharmaceuticals and health care

Pakistan Seeks Energy Loan Restructuring from China

Pakistan's finance and energy ministers are in Beijing to negotiate debt rescheduling for CPEC energy projects, amid concerns over China's reluctance and potential impact on IMF bailout.

Jul 27, 2024 16:59

India Steel Production to Cross 300MT by 2030: Official

India's steel production is projected to surpass 300 million tonnes by 2030, fueled by strong infrastructure push and robust GDP growth. The government aims to reduce carbon footprint in the steel...

Jul 27, 2024 16:43

Cholamandalam Investment Appoints Ravindra Kumar Kundu MD

Cholamandalam Investment and Finance Company has appointed Ravindra Kumar Kundu as its Managing Director for a five-year term starting October 7. Kundu has been with the company for 24 years and...

Jul 27, 2024 15:58

PNB Q1 Profit Surges Over 100% to Rs 3,252 Crore

Punjab National Bank (PNB) reported a significant jump in its Q1 FY25 profit, driven by a decline in bad loans and improved interest income. Learn more about PNB's financial performance.

Jul 27, 2024 15:50

Sugar MSP Hike: Govt Decision Expected Soon

India's government is expected to decide on a sugar MSP hike in the coming days, according to Union Food Secretary Sanjeev Chopra. The current MSP has remained unchanged since 2019, while...

Jul 27, 2024 15:40

More News »

Top News

Pakistan Seeks Energy Loan Restructuring from China

Pakistan's finance and energy ministers are in Beijing to negotiate debt rescheduling for CPEC energy projects, amid concerns over China's reluctance and potential impact on IMF bailout.

Jul 27, 2024 16:59

Marina Harley-Davidson Opens Second Dealership in Chennai

Marina Harley-Davidson has opened its second dealership in Chennai, offering sales and service for premium Harley-Davidson motorcycles. The new facility is located in Velappanchavadi.

Jul 27, 2024 16:57

India Steel Production to Cross 300MT by 2030: Official

India's steel production is projected to surpass 300 million tonnes by 2030, fueled by strong infrastructure push and robust GDP growth. The government aims to reduce carbon footprint in the steel...

Jul 27, 2024 16:43

Himachal Builds Rs 350 Cr Medical Devices Park, Rejects Central Funding

Himachal Pradesh will build a Rs 350 crore medical devices park with its own funds, rejecting central funding. The park will be built on 265 acres and will be a source of income for the state.

Jul 27, 2024 16:15

Cholamandalam Investment Appoints Ravindra Kumar Kundu MD

Cholamandalam Investment and Finance Company has appointed Ravindra Kumar Kundu as its Managing Director for a five-year term starting October 7. Kundu has been with the company for 24 years and...

Jul 27, 2024 15:58

More Top News »

Report Card

PE Ratios

EPS (Rs.)

6.87

Sales (Rs. Cr)

268.43

Face Value (Rs.)

Net Profit Margin (%)

3.83

Last Bonus

1:2

Last Dividend(%)

Return on Average Equity

10.48

Compare 'Shasun Pharmaceuticals Ltd.[Merged]' with other stocks

Sun Pharmaceutical Industries Ltd.
1,665.20
Compare

Cipla Ltd.
1,499.90
Compare

Divi's Laboratories Ltd.
4,549.75
Compare

Zydus Lifesciences Ltd.
1,205.60
Compare

Dr. Reddy's Laboratories Ltd.
6,854.20
Compare

Torrent Pharmaceuticals Ltd.
3,087.85
Compare

Apollo Hospitals Enterprise Ltd.
6,388.60
Compare

Max Healthcare Institute Ltd.
926.50
Compare

Lupin Ltd.
1,801.15
Compare

Alkem Laboratories Ltd.
5,178.80
Compare

Peers

LTP
Change (Rs.)
Change %
Mkt Cap (Rs. Cr)
Volume

12541558
0.00
0.00
0.00 %
0.00
0

12540052
0.00
0.00
0.00 %
0.00
0

12540635
0.00
0.00
0.00 %
0.00
0

12540053
0.00
0.00
0.00 %
0.00
0

14090030
0.00
0.00
0.00 %
0.00
0

12540048
0.00
0.00
0.00 %
0.00
0

12540292
0.00
0.00
0.00 %
0.00
0

16550035
0.00
0.00
0.00 %
0.00
0

16550439
0.00
0.00
0.00 %
0.00
0

12540303
0.00
0.00
0.00 %
0.00
0

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Add Shasun Pharmaceuticals Ltd.[Merged] to your Portfolio
Date of purchase
Quantity
Purchase price
Exchange	BSE BSE NSE NSE

Shasun Pharmaceuticals Ltd.[Merged]

is not listed on NSE (View BSE)

Financial Results of Shasun Pharmaceuticals Ltd.[Merged]

About Shasun Pharmaceuticals Ltd.[Merged]

News for Pharmaceuticals and health care

Top News

Report Card

Compare 'Shasun Pharmaceuticals Ltd.[Merged]' with other stocks

REDIFFGURUS

Sir, I had initially started SIP in mutual funds via...

My monthly income is around 70k no debts yet.....

I am 79 yrs old and most of my investments are in...

Sir - what would be the ideal duration for parking...

Hi, I am employed in Maldives from last one year and...

Sir, I am new and I have started investing in SIP of...

Hello Sir I am an NRI and I still have an old SB...

Shasun Pharmaceuticals Ltd.[Merged] performance snapshot

Peers

Stocks

Mutual Funds

Investment tracking

Add Shasun Pharmaceuticals Ltd.[Merged] to your Portfolio

Add Shasun Pharmaceuticals Ltd.[Merged] to your Watchlist

Add Shasun Pharmaceuticals Ltd.[Merged] to your Watchlist Alert me if price...
Goes above Rs.
Goes below Rs.